COVID-19 vaccine approved for trials, says Chinese military
The Chinese Ministry of National Defense (MND) announced on 18 March that a vaccine for the COVID-19 coronavirus, developed by the Academy of Military Medical Sciences of the People’s Liberation Army (PLA), has been approved for clinical trials.
The subunit vaccine has apparently been approved for safe testing on humans by an undisclosed (and therefore unverified) third party.
Preparations for mass production of the vaccine are also under way, the MND stated.
The team of PLA scientists worked under senior bioengineer Maj Gen Chen Wei. He has been conducting research in Wuhan, where the COVID-19 outbreak began.
A subunit vaccination includes a fragment of the pathogen that can initiate an immune response.
More from Defence Notes
-
Patria OPTIME and ILIAS: Orchestrating operational readiness across every domain
Patria OPTIME is a sustainment concept that integrates MRO and lifecycle services into one solution, powered by the ILIAS digital defence platform
-
US military seeks common controllers for drones and robotic systems
US Air Force, Army, Marine Corps and Special Operations Command initiatives signal demand for interoperable uncrewed systems control, creating opportunities for suppliers of hardware, software and integration services.
-
“Start planning much earlier”: delivering defence support in an era of disruption
In Conversation… The geopolitical landscape is increasingly uncertain, with the UK and its allies confronting the most unpredictable international environment for decades. To adapt, defence readiness must begin long before assets reach the front line, forging a resilient support enterprise that can thrive in a time of ongoing disruption, argue the partners of Team ORION.
-
“Communicating at mission speed”: why data security is essential for operational success
In conversation… Everfox’s Chairman and Chief Executive Officer Dave Wajsgras and Managing Director, International, Colin McKinty discuss the critical importance of information security in defence, minimising insider risk and the company’s international growth strategy with Shephard’s Andrew White.
-
“Engage with the operational problem”: how software innovation can boost UK defence
In Conversation… Shephard’s Andrew White talks to Zafer Şen, CEO and co-founder of OBSS, about the future of command-and-control software in the age of artificial intelligence, and his company’s ambitions in the UK defence market.